Divis Laboratories Ltd | DIVI - Cost Of Sales

Stock Price
6,024.50
Daily Change
-117.00 -1.91%
Monthly
-9.30%
Yearly
-1.89%
Q1 Forecast
5,937.24

Divis Laboratories Ltd reported INR11.86B in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Aurobindo Pharma INR 33.39B 3.98B Sep/2025
Avita Medical AUD 3.47M 1.19M Jun/2025
Divis Laboratories Ltd INR 11.86B 1.18B Sep/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
Lupin INR 21.42B 706.3M Sep/2025
Moderna USD 207M 88M Sep/2025
Organon & Co USD 745M 25M Sep/2025
Revvity USD 324.34M 3.38M Sep/2025
Tilray USD 164.37M 8.41M Sep/2025
Viatris USD 2.39B 139.2M Sep/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025